Shares of California Nanotechnologies slid to $0.22, extending a multi-session selloff after the advanced-materials manufacturer reported full fiscal year 2026 results that confirmed a painful truth: revenue is growing from new customers, but the company is still deeply unprofitable.

  • A Key Customer Vanished and Took Most of the Revenue With It

FY2026 was a "transitional year" after the complete elimination of activity from Cal Nano's green steel client, which had accounted for 63% of revenues in FY2025.

Full-year revenue came in at US$2.79 million, down 55% from the prior year. That single-client dependency turned what looked like a growth story into a restructuring exercise. The net loss for the year ballooned to US$1.86 million, compared to net income of $158,000 the year before. For a micro-cap with just $207,000 in cash , losses of that magnitude raise survival questions.

  • New Customers Are Growing Fast — From a Tiny Base Management has framed the pivot as a success. Manufacturing service revenues, excluding the green steel client, increased 85% year-over-year.

No single customer represented more than 10% of revenues. That diversification is real, but the absolute numbers remain small — a concern when fixed costs from a new Santa Ana facility and ISO certification investments keep pushing expenses higher.

  • Q4 Offered a Glimmer, but Investors Want More Proof

Q4/FY2026 delivered positive adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization — essentially, operating cash profit) of $50,329, the first positive quarter of the fiscal year.

This reflected higher revenue levels and cost savings from consolidating its Cerritos facility into Santa Ana, expected to save roughly $120,000 a year. A single slightly profitable quarter, however, hasn't been enough to reverse sentiment.

  • The Nuclear and Defense Pipeline Is Promising but Unproven

Cal Nano expects a $1.0 million initial purchase order for military brake components and has landed its first order for nuclear control rods from a small modular reactor developer.

Management says FY2027 will emphasize larger-scale contracts and non-dilutive funding. But institutional investors view the capital story skeptically, noting "limited near-term catalysts" and high risk.

Recent private placement warrants at US$0.30 also threaten future share dilution.

At $0.22, the market is pricing in doubt that Cal Nano can convert its defense and nuclear pipeline into sustainable revenue before cash runs dry. The next few quarters will determine whether this is a bargain — or a value trap.